Published in
Springer Nature [academic journals on nature.com], Oncogene, 32(37), p. 4443-4454, 2018
DOI: 10.1038/s41388-018-0291-3
Links
Tools
Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer
Journal article published in 2018 by
Sarah Yoon,
Eun-Ju Lee,
Ji-Hye Choi,
Taek Chung,
Do Young Kim,
Jong-Yeop Im,
Myung-Ho Bae,
Jung-Hee Kwon,
Hyuk-Hoon Kim,
Hyung Chul Kim,
Young Nyun Park,
Hee-Jung Wang,
Hyun Goo Woo 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 